Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus effects on brain structure and function in systemic lupus erythematosus
ChiCTR2500105712Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Kunming Medical University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sirolimus in systemic lupus erythematosus (SLE) (2 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoints: Near-infrared brain functional imaging related indexes (integral value during the task period) at week 24, Brain MRI indicators (hippocampal volume, etc.) at week 24 and 1 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ChiCTR2500105712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105712.